The Effect of Dexmedetomidine on the Microcirculation in Patients With Severe Sepsis and Septic Shock

Trial Profile

The Effect of Dexmedetomidine on the Microcirculation in Patients With Severe Sepsis and Septic Shock

Recruiting
Phase of Trial: Phase IV

Latest Information Update: 24 Dec 2016

At a glance

  • Drugs Dexmedetomidine (Primary) ; Midazolam; Propofol
  • Indications Sepsis; Septic shock
  • Focus Pharmacodynamics
  • Most Recent Events

    • 07 Jun 2017 Biomarkers information updated
    • 20 Dec 2016 Planned End Date changed from 1 Dec 2017 to 1 Dec 2018.
    • 20 Dec 2016 Planned primary completion date changed from 1 Jun 2017 to 1 Jun 2018.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top